• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>T. Rowe Price Health Sciences

T. Rowe Price Health Sciences

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  5. Research
  1. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  2. T. Rowe Price Thrives Despite a Tumultuous 2013

    The firm remains on solid footing after some unexpected manager and analyst departures.

  3. Another T. Rowe Price Manager Departs

    Rob Bartolo plans to relocate to the West Coast. Also, T. Rowe Price taps a manager to be director of research for U.S. equities.

  4. Caution: Tax Bills Ahead

    A survey of this season's capital gains distribution estimates.

  5. Caution: Tax Bills Ahead

    A survey of this season's capital gains distribution estimates.

  6. What Investors Were Researching in September

    International opportunities, income, and M&A activity were on investors' minds in September.

  7. Fund Changes Bring New Analyst Ratings

    Morningstar's Russ Kinnel examines recent fund Analyst Rating upgrades and downgrades and offers guidelines for investors who own these funds.

  8. What Investors Were Researching in May

    Investors continued their search for income in May, as the future of monetary policy came into sharp focus during the month.

  9. What Investors Were Researching in March

    As the market shrugged off new eurozone worries in March, investors remained focused on finding cheap, wide-moat stocks and income-producing investments.

  10. Our Mostly Patient Approach to Analyst Ratings

    See how the analyst ratings and star ratings for funds change over time.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.